Join us at the Global Congress on Stem Cell, Tissue Science, and Regenerative Medicine, scheduled from April 24-25, 2025, in Paris, France. This pioneering conference brings together leading scientists, researchers, clinicians, and industry experts to explore the latest advancements and applications in stem cell therapy, tissue engineering, and regenerative medicine.
Attendees will have the opportunity to engage in stimulating discussions and gain insights into cutting-edge research through keynote presentations, panel discussions, and poster sessions. The congress aims to foster collaboration among professionals from academia, healthcare sectors, and biotech industries, driving forward the development of transformative therapies and treatments.
Topics of discussion will include stem cell biology, biomaterials and scaffolds, organ regeneration, ethical considerations, clinical trials, and regulatory aspects. Participants can expect to network with peers, exchange ideas, and establish potential collaborations that could shape the future of healthcare.
Mark your calendars now and be part of this influential gathering at the Global Congress on Stem Cell, Tissue Science, and Regenerative Medicine in 2025.
Abstract Submission Deadline: Feb 26, 2025
Early Bird Registration: Feb 28, 2025
Mid Term Registration: March 14, 2025
Final/Onsite Registration: Apr 24, 2025
Group Lead, Stem cells and Differentiation, Institut de Biologie Valrose
France
Deputy Director of INRAE/Oniris Unit
France
Pro-Vice-Chancellor for Research & Impact ,University of Liverpool
United Kingdom
Medical Director of Cleveland Clinic Consortia for Pain
USA
University of Bari “Aldo Moro”
Italy
University of North Carolina at Charlotte
USA
General Director, TiPhage
Turkey
University of Bari “Aldo Moro”
Italy
Deputy Director of INRAE/Oniris Unit
France
Universite De Montreal, IRIC
France
Biogipuzkoa Health Research Institute
Spain
Alpine Spine & Orthopedics Institute
USA
UMC Healthcare
UAE
JLM ExoGrade LLC, Texas
USA
Ben-Gurion University
Israel
Dear Colleagues,
I’m delighted to welcome you to the Global Congress on Stem Cells, Tissue engineering and Regenerative Medicine 2025 to be held in the iconic European city of Paris, venue of the 2024 Olympic Games. Where better to gather as experts in the development and use of stem cell therapies to discuss the latest developments in science, translation and clinical effectiveness. Stem cell biology is still a young field and sharing our discoveries and insights will be essential if we are to find the best way of using these enigmatic cells for the benefit of patients and health providers around the world.
Whether you are a scientist, clinician, or industrial expert, we look forward to seeing you in Paris this spring.
Professor Anthony Hollander
Pro-Vice-Chancellor for Research and Impact and Professor of Stem Cell Biology
University of Liverpool, UK
and
Founder, Director, and Chief Scientific Officer
TrophiCell Ltd
Fibrosis aims to provide a unique forum through which the Fibrosis community will learn about the latest, most significant fibrosis-related advances across the life, physical, applied and social sciences. Areas of interest include fundamental, preclinical research that furthers our understanding of the mechanisms underlying scar initiation, propagation and progression; work aiming to translate this knowledge to the clinic by focusing on new approaches for the development and delivery of diagnostic and therapeutic modalities; clinical studies informing fibrosis diagnosis, treatment and prevention; and new ways of understanding the global societal impact of fibrosis.
In addition to publishing original research, Fibrosis will publish Comments, Reviews, News & Views, Features, Case Reports and Correspondence of high significance across the range of disciplines relating to fibrosis research.
https://www.sciepublish.com/journals/fibrosis